Many organisms activate adaptive transcriptional programs to help them cope with decreased oxygen levels, or hypoxia, in their environment. These responses are triggered by various oxygen sensing systems in bacteria, yeast and metazoans. In metazoans, the hypoxia inducible factors (HIFs) mediate the adaptive transcriptional response to hypoxia by upregulating genes involved in maintaining bioenergetic homeostasis. The HIFs in turn are regulated by HIF-specific prolyl hydroxlase activity, which is sensitive to cellular oxygen levels and other factors such as tricarboxylic acid cycle metabolites and reactive oxygen species (ROS). Establishing a role for ROS in cellular oxygen sensing has been challenging since ROS are intrinsically unstable and difficult to measure. However, recent advances in fluorescence energy transfer resonance (FRET)-based methods for measuring ROS are alleviating some of the previous difficulties associated with dyes and luminescent chemicals. In addition, new genetic models have demonstrated that functional mitochondrial electron transport and associated ROS production during hypoxia are required for HIF stabilization in mammalian cells. Current efforts are directed at how ROS mediate prolyl hydroxylase activity and hypoxic HIF stabilization. Progress in understanding this process has been enhanced by the development of the FRET-based ROS probe, an vivo prolyl hydroxylase reporter and various genetic models harboring mutations in components of the mitochondrial electron transport chain.
Introduction
Organisms from bacteria to metazoans have evolved oxygen (O 2 ) sensing systems whichactivate adaptive transcriptional programs during times of O 2 deprivation or hypoxia. Transcription factors known as hypoxia inducible factors (HIFs) are the major effectors of the hypoxic transcriptional response in metazoans. HIF activity is not only affected by cellular O 2 levels but also by reactive oxygen species (ROS) produced during hypoxia. This review will discuss technologies employed to measure ROS, how hypoxia affects cellular ROS levels, evidence supporting a role for ROS in cellular O 2 sensing and potential mechanisms by which ROS regulate HIF activity.
Cellular Oxygen Sensing
Aerobic life depends on O 2 to generate ATP. Since organisms often encounter decreased O 2 levels, or "hypoxia" in their environment, they have evolved various O 2 -sensing systems that trigger adaptive responses to help them maintain cellular and systemic energy homeostasis. Several O 2 sensors have been described in bacteria, most of which respond to the O 2 -dependent redox status of the cell. For example, decreased O 2 levels in E. Coli results in activation of the fumarate and nitrate reduction (FNR) transcription factor, via effects on the bound iron-sulfur cluster, which activates an adaptive transcriptional program [1] . In parallel with the FNR system in E. Coli, the two-component Arc A/B system induces transcription of adaptive genes in response to the redox state of electron carriers during hypoxic stress [2, 3] . During O 2 deprivation in Rhizobia and Bradyrhizobia, O 2 is released from a heme moiety bound to the histidine kinase FixL which subsequently undergoes autophosphorylation and activates the transcription factor FixJ [4, 5] .
Many O 2 sensing mechanisms have also been described in eukaryotes. In yeast, decreased de novo synthesis of sterol and heme due to O 2 limitation affects the activities of multiple transcription factors, such as Hap1 and Sre1 [6, 7] . In metazoans, O 2 sensing systems are more complicated. Unlike unicellular organisms, whose O 2 sensors are most sensitive to anoxic conditions, metazoans have evolved a more graded response to O 2 levels due to the heterogeneity of O 2 concentrations throughout tissues. For instance, in mammals normal O 2 tensions in the lung are around 16% while other tissues are approximately 2-5%. In addition, metazoans must also elicit systemic adaptations to hypoxia which require multiple and more complex O 2 sensing mechanisms beyond simple metabolic adaptations.
In metazoans, the major hypoxic transcriptional response is mediated by hypoxia inducible factors (HIFs) [8, 9] . Standard and conditional knock-out mouse models have demonstrated a role for HIFs in embryonic vasculogenesis, as well as adult erythropoesis and the inflammatory response [10] [11] [12] [13] . HIF is a heterodimeric transcription factor complex consisting of a constitutively stabilized β subunit and a more labile α subunit [14] . HIF transcriptional activity dramatically increases during hypoxia and leads to enhanced expression of hundreds of genes involved in maintaining homeostasis at the cellular, tissue and systemic level [15] . HIF complex activity is mainly mediated by protein stability of the α subunit [14, [16] [17] [18] . Under normoxic conditions (21% O 2 ), HIFα is continuously degraded by the 26S proteasome which is dependent on the hydroxylation of two key proline residues within the oxygen-dependentdegradation domain (ODDD) [19] [20] [21] [22] . This hydroxylation allows an E3 ubiquitin ligase complex containing the von Hippel-Lindau protein (pVHL) to bind HIFα, earmarking it for degradation by the proteasome [18] . Under hypoxic conditions, HIFα is no longer hydroxylated and therefore no longer binds pVHL, allowing it to escape recognition by the proteasome. It can then translocate to the nucleus, dimerize with the β subunit and activate the transcription of target genes such as phosphoglycerate kinase and vascular endothelial growth factor [19, [21] [22] [23] . O 2 -sensitive hydroxylation of HIFα is regulated by HIF-specific prolyl hydroxylases (PHDs), dioxygenases that use O 2 and 2-oxoglutarate as co-substrates to carry out the hydroxylation reaction. In addition, PHDs require iron in the ferrous state for their activity and ascorbate to recycle that iron when oxidized in uncoupled hydroxylation reactions (Figure 1 ) [19, 23] .
Mammalian cells express three HIF-specific PHDs, PHD1, PHD2 and PHD3, though studies have shown PHD2 to be the most important regulator of HIF stabilization [24] . Since PHDs have a high K m for O 2 in vitro, which presumably makes their activity sensitive to O 2 tensions found in tissues, a simple regulatory model has been proposed whereby PHDs' ability to hydroxylate HIFα, and thereby "sense O 2 ," is dictated by O 2 availability. However, modes of regulation other than mere O 2 availability have been reported. Some data suggest that byproducts of the tricarboxylic acid cycle such as succinate, malate and fumarate can inhibit PHD2 activity and stabilize HIFα when allowed to accumulate in cells or when added to in vitro hydroxylation reactions [25] [26] [27] . In addition, extensive data from multiple groups have suggested a role for mitochondrial reactive oxygen species (ROS) in regulating HIFα stabilization [28] [29] [30] [31] The importance of ROS in cellular O 2 sensing has been hotly debated and will be a focus of the latter part of this review. We will first focus on cellular sources of ROS, the methodology employed in measuring ROS and the relationship between ROS and mitochondria.
Types and Sources of Cellular ROS
Diatomic oxygen is a relatively non-reactive molecule that becomes highly reactive by gaining one electron to form superoxide anion (O 2 .− ), two electrons to form hydrogen peroxide (H 2 O 2 ), or three electrons to form hydroxyl radical (.OH). Cellular O 2 .− can dismutate into H 2 O 2 spontaneously or by the enzymatic activites of cellular superoxide dismutates (SODs), the latter contributing to the majority of intracellular H 2 O 2 . Compared to O 2 .− , H 2 O 2 is much more stable and can diffuse through biological membranes giving it the potential to act as a long-range signaling molecule [32] [33] [34] . Recent work has shown that ROS can serve as a regulated and specific second-messengers to propagate signals in multiple settings [35] .
The main site of cellular ROS production is the mitochondrial electron transfer chain (ETC). Though it is commonly reported that 1-2% of electron flow on the ETC leads to ROS production, more recent reports show this value to be as low as 0.15%, depending on the carbon source being oxidized [36, 37] . A high concentration of mitochondrial SOD ensures no significant O 2 .− accumulation beyond its initial site of production and allows for the generation of H 2 O 2 which has second messenger effects in the cytosol [31, [38] [39] [40] . The endoplasmic reticulum (ER) is another cellular source of ROS where resident cytochrome P-450 and b 5 family members oxidize unsaturated fatty acids and xenobiotics to generate O 2 .− and H 2 O 2 [41] [42] [43] . In addition, plasma membrane-associated oxidases such as NADPH oxidases generate ROS by oxidizing intracellular NADPH to reduce O 2 into O 2 .− in order to achieve localized microbicidal function in phagosomes [44] [45] [46] [47] . Peroxisomes contain multiple H 2 O 2 -generating enzymes including peroxisomal catalase which metabolizes toxic molecules such as ethanol. However, only a small percentage of peroxisomal H 2 O 2 may escape this organelle [48] . Some soluble oxidases, dehydrogenases and dioxygenases in the cytoplasm can also generate ROS during catalytic cycling [49] . In summary, while many sources of intracellular ROS exist, the most significant contribution comes from the mitochondrion, which has also been shown to play the most important role in cellular O 2 sensing.
Measurement of Cellular ROS
Compared to other biological metabolites, intracellular ROS are highly reactive and very shortlived, making their measurement a challenge. Currently there are no direct methods for measuring intracellular ROS levels. Some existing methods assay the downstream effects of ROS on cellular macromolecules such as lipid oxidation, protein carbonylation or the formation of 8-oxoguanine in DNA as a readout for ROS production [49, 50] . More commonly used assays for assessing intracellular ROS levels involve loading cells with luminescent chemicals and fluorescent dyes which cross-react with different types of ROS to emit light. One example is lucigenin (Luc 2+ ) which, after being reduced to LucH .+ within the cell, can react with O 2 .− to form an unstable product that chemiluminesces. [54, 55] . Moreover, both lucigenin and DCFH have been shown to yield a fluorescent signal in the absence of ROS, giving rise to the potential for high background and false positive readings [56] [57] [58] . In addition to these limitations, one must also assume that cellular uptake of DCFH-DA is equivalent under different conditions if a direct comparison is to be made. Finally, indirect effects of the experimental manipulation itself must also be considered. For instance, with the DCF fluorescence probe, an excitation violet-blue light is required, a wavelength which has been linked to cellular phototoxicity and H 2 O 2 generation [59] .
A recently developed fluorescence resonance energy transfer (FRET)-based assay holds potential to circumvent the limitations of chemical-based methods. In this assay, cyan and yellow-fluorescent proteins are bridged by part of a bacterial heat shock protein [29, 60] which contains redox-sensitive cysteine thiols [61, 62] . The thiol groups are reduced at normal conditions but upon oxidation, a disulfide bond is formed that changes the conformation of the hinge domain and separates the YFP and CFP. This decreases the energy transfer from CFP to YFP enhancing the CFP signal while decreasing the YFP signal during oxidation [63] . Such a probe can be overexpressed in cells and the ratio of CFP to YFP fluorescence taken as a measure of cellular ROS levels in real time, a readout independent of probe concentration. Though this technology eliminates concerns of equal probe distribution across samples and indirect effects from excessive experimental manipulation, it will be of interest to determine exactly which types of ROS affect the activity of this FRET probe.
ROS and Hypoxia
Though it is generally accepted that intracellular ROS levels change during hypoxia, in which direction this change occurs is still hotly debated. From an intuitive standpoint, one might assume that ROS levels drop during hypoxia since ROS require O 2 as a substrate for their production and several studies support this prediction. For instance, it has been shown that endothelial cell plasma membranes release less extracellular H 2 O 2 under hypoxia compared to normoxia [64, 65] . In addition, perinuclear endoplasmic reticulum (ER) generation of OH, presumably derived from the "Fenton reaction" of H 2 O 2 with transition metals, is higher under normoxic conditions compared to hypoxia [66] . Presumably, these studies are assessing the specific ROS-generating capacity of NADPH oxidase, the major ROS producer at the plasma membrane and in the ER. Other studies which assess total intracellular ROS content have made opposite observations. Using either DCFH and FRET technology discussed above, several groups have found an increase in total intracellular ROS upon exposure to hypoxia [29] [30] [31] 67] . In addition, it has been shown that protein cabonylation and formation of 8-hydroxy-2′-deoxyguanosine (8-OH-dG) in DNA both increase in yeast exposed to anoxia, an indirect indication that ROS increase during this stress [68] . In this same study, expression of SOD1 also increased, a further indirect confirmation that ROS increase during O 2 limitation. In all, inconsistencies in reports on the direction and degree of hypoxic ROS production likely stem from differences in cell types and subcellular compartments examined as well as the inadequacy of current technology to accurately measure ROS levels. Establishing a reliable, quantitative and sensitive method for measuring ROS will be an important step in validating the role of ROS in the hypoxic response.
Role of ROS in Cellular O 2 Sensing
The role of ROS in regulating the hypoxic response and HIF activity has remained controversial for over a decade. Early theories on the subject suggested that NADPH oxidase might be an important ROS-generating cellular O 2 sensor since this multi-subunit membrane-bound enzyme is expressed in tissues implicated in systemic hypoxic responses and affects cellular redox status depending on cellular O 2 concentrations [69, 70] . However more in-depth studies did not support a requirement for NADPH in the hypoxic adaptive response [71] . Chandel et al later suggested that mitochondria are the source of ROS involved in the hypoxic response by showing that ρ° cells (which lack functional mitochondria) or treatment of cells with either inhibitors of the mitochondrial electron transport chain or antioxidants impede HIFα activation, though others failed to observe any effect of antioxidants on HIFα stabilization [31, 72] . Experiments that utilized broader panels of specific inhibitors for each of the electron transport chain complex components later suggested that an important source of hypoxic ROS is complex III [39, [73] [74] [75] . More recent studies further strengthen a role for mitochondrial ROS in hypoxic responses by utilizing genetic models showing that deficiencies in various mitochondrial electron transport chain components compromise hypoxic HIFα stabilization. These genetic models are improved systems for studying the effects of mitochondrial electron transport inhibition, as they elminate the effects of non-specificity encountered with chemical inhibitors.
For example, genetic ablation of cytochrome c by targeted mutagenesis in murine embryonic cells or shRNA-mediated knockdown of the Rieske iron-sulfur protein of Complex III in HEK293 cells and 143B osteosarcoma cells attenuates hypoxic, but not anoxic, HIFα stabilization suggesting severe O 2 limitation is sensed differently from more moderate hypoxia [29, 30] . Interestingly, in the same studies, it was also shown that human fibroblasts with a deficiency in electron transport chain Complex IV, though defective in oxidative phosphorylation, maintained HIFα stabilization under hypoxia [28] . These results suggest that Complex III of the mitochondrial electron transport chain is the ROS-generating O 2 sensor responsible for HIFα stabilization during hypoxia.
The idea that ROS might contribute to O 2 sensing has been hotly contested, especially following the discovery of the HIF-specific prolyl hydoxylases, after which many assumed intracellular O 2 must be the only determinant of hydroxylase and HIFα activity. In direct contrast to previous findings, some groups found that ρ° cell lines lacking functional mitochondria still stabilize HIFα under hypoxia [76, 77] . Other studies suggested that cells with impaired mitochondrial function fail to stabilize HIFα under hypoxia, not because of defective ROS-generation, but because of intracellular O 2 re-distribution which leads to increased availability of O 2 as a substrate for the hydroxylation reaction [72, 78] . Although these reports challenge a role for mitochondrial ROS in cellular O 2 sensing, they do not explain why antioxidants, including the recently described mitochondrially-targeted compound MitoQ, block hypoxic HIFα activity [79] . In addition, they do not explain why defects which specifically compromise Complex III function prevent hypoxic HIFα activity, while Complex IV defects, that impair cellular respiration and presumably O 2 distribution, leave the hypoxic response intact [28] . Complete validation of the importance of mitochondrial ROS most likely awaits the elucidation of the mechanisms by which ROS regulate HIFα stability during hypoxia.
Potential mechanisms for ROS in cellular O 2 sensing
There are many possible mechanisms by which mitochondrial ROS regulate HIFα stability during hypoxia. These most likely involve the PHDs, since recent work employing a cellular prolyl hydroxylase reporter, which utilizes hydroxylation-specific mobility shifts on SDS-PAGE gels to monitor the hydroxylation of HIFα in vivo, showed that mitochondrial inhibitors and the anti-oxidant Mito-Q affect cellular hydroxylase activity [26] . One report has shown that elevated ROS levels due to genetic ablation of the transcription factor JunD and consequent downregulation of its anti-oxidant target genes, leads to PHD2 inactivation via oxidation of ferrous iron in the catalytic domain as determined by electron paramagnetic resonance spectroscopy [80] . However, it remains to be determined whether physiological levels of ROS produced during hypoxia can have the same effect on PHD2. Another plausible mechanism is that ROS alter the disulfide bond structure of PHD2 to inhibit its activity, a mode of regulation that has been well described for protein tyrosine phosphatases [66, 81] . The recent discovery of the crystal structure of PHD2 may be an important step in assessing this possibility [82] . A final plausible mechanism by which ROS might affect the hypoxic response is the initiation of a signal transduction cascade resulting in inhibitory post-translational modifications on PHD2 (Figure 2 ). In support of this mechanism, recent work has shown that the p38 stressactivated MAPK cascade is involved in ROS-dependent hypoxic responses as mouse embryonic fibroblasts lacking either p38 MAPK or its upstream effectors MKK3/6 fail to stabilize HIFα under hypoxia and oxidant stress [83] .
Summary
While there is no doubt that O 2 substrate limitation can regulate PHD2 activity, it seems unlikely that this is the only determinant of HIFα stimulation in the complex environment of the cell. There is much evidence to suggest that other cellular factors, especially mitochondrial ROS, play a significant role in the hypoxic response. The development of reagents such as cellular genetic models like the cytochrome c null cells, the ROS-sensitive FRET probe and the in vivo hydroxylase reporter will most likely aid in uncovering the precise mechanism by which ROS participates in cellular O 2 sensing. PHD2 utilizes cellular O 2 and 2-oxoglutarate as co-substrates to hydroxylate two proline residues on HIFα. PHD2 also requires ferrous iron for its activity and ascorbate to recycle oxidized iron during uncoupled reactions. ROS may trigger a signal transduction cascade which results in post-translational modifications on PHD2, may oxidize bound iron, or may alter PHD2 disulfide bond structure to regulate PHD2 activity.
